{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T12:23:17Z","timestamp":1772540597099,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.urolonc.2020.07.027","type":"journal-article","created":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:33:43Z","timestamp":1598142823000},"page":"73.e19-73.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prostate cancer presentation, treatment selection, and outcomes among men with HIV\/AIDS: A clinical stage, race, and age-matched contemporary analysis"],"prefix":"10.1016","volume":"39","author":[{"given":"Maria","family":"Ruden","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher H.","family":"Olivares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew Q.","family":"Fakhoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Roston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia P.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney M.P.","family":"Hollowell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah P.","family":"Psutka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.07.027_bib0001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","article-title":"The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals","volume":"24","author":"Ray","year":"2010","journal-title":"Aids"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0002","doi-asserted-by":"crossref","first-page":"e81355","DOI":"10.1371\/journal.pone.0081355","article-title":"Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada","volume":"8","author":"Samji","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0003","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/jnci\/94.16.1204","article-title":"Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998","volume":"94","author":"Eltom","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0004","first-page":"2016","article-title":"Time trends in cancer incidence in persons living with HIV\/AIDS in the antiretroviral therapy era: 1997-2012","volume":"30","author":"Park","year":"1795","journal-title":"Aids"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0005","doi-asserted-by":"crossref","first-page":"866","DOI":"10.7326\/M17-2499","article-title":"Projected cancer incidence rates and burden of incident cancer cases in HIV-infected adults in the United States through 2030","volume":"168","author":"Shiels","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0006","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11908-018-0626-9","article-title":"Are non-HIV malignancies increased in the HIV-infected population?","volume":"20","author":"Thrift","year":"2018","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jiph.2014.08.003","article-title":"Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV\/AIDS: a systematic review","volume":"8","author":"Cobucci","year":"2015","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0008","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/QAD.0000000000000163","article-title":"Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States","volume":"28","author":"Robbins","year":"2014","journal-title":"Aids"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0009","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1158\/1055-9965.EPI-16-0964","article-title":"Excess mortality among HIV-infected individuals with cancer in the United States","volume":"26","author":"Coghill","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0010","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2014.59.5967","article-title":"Elevated cancer-specific mortality among HIV-Infected patients in the United States","volume":"33","author":"Coghill","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0011","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1055-9965.EPI-14-1079","article-title":"Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers","volume":"24","author":"Marcus","year":"2015","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0012","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.urology.2014.09.054","article-title":"Clinical presentation and outcomes of prostate cancer in an urban cohort of predominantly African American, human immunodeficiency virus-infected patients","volume":"85","author":"Riedel","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0013","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1002\/cncr.30052","article-title":"Disparities in cancer treatment among patients infected with the human immunodeficiency virus","volume":"122","author":"Suneja","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0014","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1200\/JCO.2013.54.8644","article-title":"Cancer treatment disparities in HIV-infected individuals in the United States","volume":"32","author":"Suneja","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0015","first-page":"2014","article-title":"Are HIV-infected men vulnerable to prostate cancer treatment disparities?","volume":"23","author":"Murphy","year":"2009","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0016","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.eururo.2016.08.047","article-title":"Temporal trends and the impact of race, insurance, and socioeconomic status in the management of localized prostate cancer","volume":"71","author":"Gray","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0017","first-page":"290","article-title":"Cancer statistics for African Americans, 2016: progress and opportunities in reducing racial disparities","volume":"66","author":"DeSantis","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0018","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1055-9965.EPI-16-0976","article-title":"Insurance status and racial disparities in cancer-specific mortality in the United States: a population-based analysis","volume":"26","author":"Pan","year":"2017","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0019","first-page":"2016","article-title":"Clinical characteristics and outcomes of HIV-seropositive men treated with surgery for prostate cancer","volume":"48","author":"Izadmehr","year":"1639","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/pcan.2010.35","article-title":"Robot-assisted laparoscopic radical prostatectomy in men with human immunodeficiency virus","volume":"13","author":"Silberstein","year":"2010","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0021","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrurol.2010.61","article-title":"Management of prostate cancer in HIV-positive patients","volume":"7","author":"Wosnitzer","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"Suppl 1","key":"10.1016\/j.urolonc.2020.07.027_bib0022","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/QAI.0b013e31825a3668","article-title":"HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group","volume":"60","author":"High","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0023","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.psym.2014.08.004","article-title":"Prevalence of psychiatric and substance abuse symptomatology among HIV-infected gay and bisexual men in HIV primary care","volume":"56","author":"O'Cleirigh","year":"2015","journal-title":"Psychosomatics"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0024","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1200\/JCO.2007.14.5532","article-title":"Including persons with HIV infection in cancer clinical trials","volume":"26","author":"Persad","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0025","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00595-011-0096-2","article-title":"The attitudes of British surgical trainees about the treatment of HIV-infected patients","volume":"42","author":"Griffin","year":"2012","journal-title":"Surg Today"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0026","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bjps.2008.02.002","article-title":"HIV and the surgeon","volume":"61","author":"Nelson","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0027","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10461-006-9152-0","article-title":"Drug use and medication adherence among HIV-1 infected individuals","volume":"11","author":"Hinkin","year":"2007","journal-title":"AIDS Behav"},{"key":"10.1016\/j.urolonc.2020.07.027_bib0028","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1200\/JOP.2010.000076","article-title":"Perspectives on adherence and persistence with oral medications for cancer treatment","volume":"7","author":"Hohneker","year":"2011","journal-title":"J Oncol Pract"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920303653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920303653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:28Z","timestamp":1761041968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920303653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1078143920303653"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.07.027","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prostate cancer presentation, treatment selection, and outcomes among men with HIV\/AIDS: A clinical stage, race, and age-matched contemporary analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.07.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}